Fielmann Group company profile
Company profile
Fielmann Group has 18,213 employees and is headquartered in Hamburg, Germany.
Sales of Fielmann Group AG reach customers in Germany, Switzerland, Austria, Spain and North America, as well as in other markets abroad. The group works in vision care and audiology, designing and selling vision aids such as spectacles, lenses and contact lenses, hearing systems and protective equipment. Its products are sold under several brands, including fielmann and Optika Clarus, through retail stores, digital channels and the Befitting online optical platform. The company was renamed Fielmann Group AG in July 2023, having been founded in 1972.
In the fiscal year ended 31 December 2025, revenue reached €2.4 billion, up 7.4% on the previous year, and net income amounted to €203.7 million. The group had 18,213 employees and is headquartered in Hamburg, Germany. It operates as a subsidiary of Korva SE.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Germany
- Headquarters
- Fuhlsbuettler Strasse 399, 22309, Hamburg
- Employees
- 18,213
- Chief executive
- Marc Fielmann
- Founded
- 1972
- Fiscal year
- January - December
- Listing
- FIE · Xetra
- Currency
- EUR
- ISIN
- DE0005772206
- Website
- fielmann-group.com
Fielmann Group and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Fielmann GroupFIE | Germany | $3.93B | 18,213 | 13.7% | 16.4 |
| SCHOTT Pharma1SXP | Germany | $3.74B | 5,002 | 16.4% | 25.1 |
| Tecan GroupTECN | Switzerland | $3.58B | 3,000 | 4.9% | — |
| Carl Zeiss MeditecAFX | Germany | $3.07B | 5,784 | 7.2% | 23.3 |
| OttobockOBCK | Germany | $2.68B | 9,455 | 18.7% | 19.0 |
| ConvaTec GroupCTEC | United Kingdom | $6.66B | 10,000 | 16.3% | 53.2 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
